Results 261 to 270 of about 95,392 (311)

Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome. [PDF]

Genome Med
Shtossel O, Eshel A, Fried S, Geva M, Danylesko I, Yerushalmi R, Shem-Tov N, Fein JA, Fabbrini M, Shimoni A, Turjeman S, Louzoun Y, Nagler A, Koren O, Shouval R.   +14 more
europepmc   +1 more source

Acute Eruption in a Child With Acute Lymphoblastic Leukemia

Pediatric Dermatology, EarlyView.
L. Parra‐Navarro, N. Planella‐Fontanillas, C. Prat   +2 more
wiley   +1 more source

Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in Taiwan. [PDF]

Open Forum Infect Dis
Wang YW, Cheng CN, Lin CT, Tsai XC, Huang JD, Hsieh ZD, Liao XW, Lin FJ, Chen YC, Kuo CH, Wu SJ, Lin SW.   +11 more
europepmc   +1 more source

CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. [PDF]

Mediterr J Hematol Infect Dis
Olivari E, Pavoni C, Algarotti A, Micò MC, Finazzi MC, Cavallaro G, Rambaldi B, Rizzuto G, Lussana F, Rambaldi A, Grassi A.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Allogeneic Hematopoietic Stem Cell Transplantation

Therapeutic Apheresis and Dialysis, 2003
Abstract: More than 30 years have passed since the first clinical application of allogeneic bone marrow transplantation to treat hematological diseases. In recent years, the availability of peripheral blood and cord blood as additional sources of stem cells other than bone marrow has expanded the applicability of hematopoietic stem cell transplantation.
Shunro, Kai, Hiroshi, Hara
openaire   +2 more sources

Nonablative allogeneic hematopoietic stem cell transplantation

Current Opinion in Oncology, 2001
During the past few years there has been an explosion of knowledge in nonablative allogeneic stem cell transplantation. This approach to transplantation relies more on the creation of "immunologic space" for engraftment rather than the more traditional approach of creating "physical space" by the application of either intensive radiation or chemical ...
R D, Dansey, R D, Baynes
openaire   +2 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma

Clinical Lymphoma, 2004
For patients with relapsed or refractory Hodgkin's or non-Hodgkin's lymphomas, allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option when autologous HSCT fails to achieve durable remission or is deemed inappropriate. Allogeneic HSCT can result in long-term survival even in patients with refractory lymphomas.
Robert M, Dean, Michael R, Bishop
openaire   +2 more sources

Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Nursing Forum, 2015
A 32-year-old woman named A.C. was diagnosed five years ago with stage IIIB nodular sclerosing Hodgkin lymphoma (HL). Following initial chemotherapy, she had refractory disease as evidenced by hypermetabolic activity on positron-emission tomography (PET) scan. A.C.
Tracy, Robinson, Erin, Streu
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

Blood, 2003
Abstract Fifty-six patients, 10 to 66 years of age, with idiopathic myelofibrosis (IMF) or end-stage polycythemia vera or essential thrombocythemia received allogeneic hematopoietic cell transplants from related (n = 36) or unrelated (n = 20) donors.
H Joachim, Deeg, Theodore A, Gooley, Mary E D, Flowers, George E, Sale, John T, Slattery, Claudio, Anasetti, Thomas R, Chauncey, Kristine, Doney, George E, Georges, Hans-Peter, Kiem, Paul J, Martin, Effie W, Petersdorf, Jerald, Radich, Jean E, Sanders, Brenda M, Sandmaier, E Houston, Warren, Robert P, Witherspoon, Rainer, Storb, Frederick R, Appelbaum   +18 more
openaire   +2 more sources